AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback
AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback · Investor's Business Daily

In This Article:

AbbVie stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep.